Reporter March 17 2023

New executive director of Vanderbilt Health and Wellness Lori Rolando, MD, MPH, left, with Mary Yarbrough, MD, MPH, who had served as executive director of the program since 1994.

Rolando transitions to lead Health and Wellness

Scientists resurrect a ‘dead’ antibody to study protein

Vanderbilt was part of a multi-center team that resurrected a “dead antibody” to reveal the mysteries of cytochrome c, a versatile protein that is an essential part of the cell’s energy-generating capacity, and of life itself.

Vanderbilt heart patient Tony Raia, with his wife, Jenn, and daughter, Gabriella, 6, at their home in Franklin, Tennessee.

Multispecialty expertise key to heart patient’s recovery

Vanderbilt’s multispecialty expertise helped a seemingly healthy 54-year-old man who needed major heart procedures get back to the gym and live a healthy life.

Cardiovascular research pioneer Inagami mourned

Tadashi Inagami, PhD, DSc, Vanderbilt University Professor of Biochemistry, emeritus, who helped characterize the biochemical basis for hypertension, heart failure and vascular disease, died in Pittsburgh, Pennsylvania, March 13 after a brief illness. He was 92.

The locker is filled with basic necessities to help patients and caregivers with their medical care journeys.

Football player’s donation honors his late brother

P.U.N.T. Pediatric Cancer Collaborative, along with Buffalo Bills football player Dawson Knox, recently presented Monroe Carell Jr. Children’s Hospital at Vanderbilt with a gift of “Luke’s Locker” in memory of his brother.

Research by Mingjian Shi, PhD, left, Jonathan Mosley, MD, PhD, Kerry Schaffer, MD, MSCI, and colleagues found that polygenic risk score does not improve prediction of aggressive prostate cancer.

Study evaluates polygenic risk score for prostate cancer risk prediction

A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.

1 2